GenIP raises £350,000 in discounted share placing to fund AI-led growth

An update from GenIP Plc ( (GB:GNIP) ) is now available.

GenIP Plc, an AIM-quoted AI-driven innovation consultancy, has raised £350,000 before expenses through a discounted placing of 5,000,000 new shares at 7p each, equivalent to roughly 24.4% of its existing share capital. The funding comes as the company reports positive trading, deeper ties with academic clients and a growing international footprint, including new contracts in Peru and Spain that expand its presence across South America and Europe.

The company plans to allocate £100,000 of the proceeds to staffing, £150,000 to research and development for new products and platform enhancements, and £100,000 to general working capital, supporting its efforts to monetise an expanding network of partnerships and alliances. Admission of the new shares to AIM is expected around 8 May 2026, which will increase GenIP’s issued share capital to 25,517,461 shares, dilute the Concert Party’s holding from 60.88% to 48.95% and strengthen the balance sheet while broadening the free float.

CMC Markets has been appointed as GenIP’s joint corporate broker in addition to acting as sole placing agent, signalling an effort to deepen the company’s access to capital markets and investor audiences. Management argues the raise positions GenIP to accelerate product development and commercial execution through FY2026, potentially reinforcing its competitive position in the emerging niche of generative AI-enabled innovation analytics and talent solutions.

More about GenIP Plc

GenIP Plc is a technology consultancy that sits at the intersection of generative AI and innovation strategy, helping corporates, venture funds and research institutions evaluate, commercialise and scale breakthrough technologies. The company offers an AI-powered Invention Intelligence product suite that assesses the commercial potential of emerging technologies, alongside talent and executive search services that use machine learning and NLP to match innovation-driven organisations with commercialisation-focused leadership.

Together these service lines form a unified GenAI-enabled platform for innovation triage and commercialisation, supporting evidence-based decisions on R&D, investment and IP strategy while de-risking scale-up for clients. GenIP is pursuing a strategy built on organic expansion, deepening its AI-enabled services and making bolt-on acquisitions, with a vision to become a global leader in generative AI analytics for innovation commercialisation.

Average Trading Volume: 61,197

Technical Sentiment Signal: Sell

Current Market Cap: £2.21M

Learn more about GNIP stock on TipRanks’ Stock Analysis page.